Viewing StudyNCT04388384



Ignite Creation Date: 2024-05-06 @ 2:38 PM
Last Modification Date: 2024-10-26 @ 1:35 PM
Study NCT ID: NCT04388384
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-10-24
First Post: 2020-05-05

Brief Title: Real-life Pan-HER-blockade With Neratinib
Sponsor: Pierre Fabre Pharma GmbH
Organization: Pierre Fabre Pharma GmbH

Organization Data

Organization: Pierre Fabre Pharma GmbH
Class: INDUSTRY
Study ID: NIS07075
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Pierre Fabre Pharma GmbH
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
iOMEDICO AG INDUSTRY
Pierre Fabre Pharma Austria UNKNOWN
Pierre Fabre Pharma AG INDUSTRY